Jazz Pharmaceuticals plc 4

Director Rick E. Winningham received an equity award of 1,605 restricted stock units of Jazz Pharmaceuticals plc, bringing his direct holdings to 11,172 ordinary shares.

On August 5, 2026, non-employee director Rick E. Winningham received an award of 1,605 restricted stock units representing ordinary shares of Jazz Pharmaceuticals plc under the company’s 2007 Amended and Restated Non-Employee Directors Stock Award Plan. The RSUs were granted at no cash cost (reported price of $0.0 per share) and will vest in full on July 23, 2027, subject to his continued service and certain additional conditions. Following this award, Winningham’s direct holdings in Jazz ordinary shares increased to 11,172 shares, enhancing his equity-based alignment with shareholders through routine director compensation rather than an open-market purchase or sale.

Filing Facts

CIK

1232524

Ticker

JAZZ

Form

4

Source Type

fda

Accession

0001302443-26-000010

Alert Tier

5